All4NutraNo products in the cart.
All4NutraStartseite » Suppliers » Dr. Paul Lohmann
This year CPHI Europe opens its doors in Milan at Fiera Milano. From 6th to 8th October you can have a...
Abstract Two major challenges for developers of drug-releasing vaginal rings are (i) the formulation and release of hydrophilic water-soluble actives,...
Abstract Oral medications available for Parkinson's disease require multiple administrations, which significantly affects the plasma concentration of the drug, and...
Abstract Purpose To overcome the strong inter-particulate interactions between the drug and carrier in dry powder inhalers (DPIs), an amorphous...
Abstract The physical stability of salbutamol amorphous solid dispersion (ASD) pharmaceutical tablets, manufactured via a novel strategy employing liquid drug...
Abstract Background: Existing therapies for xerostomia are primarily symptomatic, providing temporary mucosal hydration without addressing underlying pathological changes in the...
Abstract Background/Objectives: Accurate determination of active pharmaceutical ingredient (API) particle size within dry powder inhaler (DPI) formulations is essential for ensuring...
Abstract Background: Phytocannabinoids such as cannabidiol (CBD) and cannabigerol (CBG) have received increasing attention in the context of inflammatory and...
Abstract Introduction Fungal infections are common in tropical regions like India, with Candida albicans being a major causative agent. Ketoconazole, a broad-spectrum...
Abstract Dextrin-based nanosponges (D-NS) are promising candidates for oral drug delivery due to their biocompatibility, mucoadhesive properties, and tunable swelling...
Copyright: PharmaExcipients AG